NDC 49884-321-52 - Olanzapine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49884-321
- Requested NDC
- 49884-321-52
- Package NDCs from labels
- 49884-321-52, 49884-321-55
- Manufacturer
- Par Pharmaceutical, Inc.
- Effective date
- 2021-07-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Olanzapine - Par Pharmaceutical, Inc. | Par Pharmaceutical, Inc. | 2021-07-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Olanzapine - A-S Medication Solutions | A-S Medication Solutions | 2021-06-16 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49884-321-52 | EA - Each | 49884-321 | 24ba7eaa-da74-4286-869e-a9d794c4737a | 1 | 2013-02-13 |
| 49884-321-55 | EA - Each | 49884-321 | c3e092d2-7419-4730-bc87-21186002ad89 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| OLANZAPINE | ACTIVE INGREDIENT | N7U69T4SZR | OLANZAPINE TABLET, ORALLY DISINTEGRATING [PAR PHARMACEUTICAL, INC.] | 3 | |
| OLANZAPINE | ACTIVE MOIETY | N7U69T4SZR | OLANZAPINE TABLET, ORALLY DISINTEGRATING [PAR PHARMACEUTICAL, INC.] | 3 | |
| MAGNESIUM SULFATE, UNSPECIFIED | INACTIVE INGREDIENT | DE08037SAB | OLANZAPINE TABLET, ORALLY DISINTEGRATING [PAR PHARMACEUTICAL, INC.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olanzapine | OLANZAPINE | Lannett Company, Inc. | 002dd00f-7946-ea4f-e063-6294a90a5916 | 2023-07-10 | Boxed warning, Warnings, Adverse reactions | 312076 N7U69T4SZR |
| Theraworx Relief for Foot Cramps Foam | MAGNESIUM SULFATE, UNSPECIFIED FORM | AVADIM HOLDINGS, INC. | 2f7fe6b7-deb0-4bf7-a8cb-15ae468512da | 2023-04-25 | Warnings | DE08037SAB |
| Olanzapine | OLANZAPINE | Bryant Ranch Prepack | 09e48e71-4dd2-4538-91d7-5b284f6647d8 | 2023-03-29 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Proficient Rx LP | ce66d545-015b-41d5-80c3-964d78e36bfd | 2023-02-01 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Concept DHA | VITAMIN- MINERAL OMEGA-3 SUPPLEMENT | U.S. Pharmaceutical Corporation | bd2051f7-b887-46f6-8d4a-b099fcd08629 | 2022-11-08 | Warnings | DE08037SAB |
| Concept OB | VITAMIN MINERAL SUPPLEMENT | U.S. Pharmaceutical Corporation | 37992a25-68bd-4050-b936-596ddedc25a3 | 2022-11-08 | Warnings, Adverse reactions | DE08037SAB |
| Olanzapine | OLANZAPINE | Dr. Reddy's Laboratories Ltd. | 9a57a63e-f856-aafa-037a-c08f2fea6496 | 2022-10-03 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Proficient Rx LP | 1f4a2eaf-3a12-4ebe-b97f-0a7bfbc32572 | 2022-10-01 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| d29c0ad5-8599-40b4-983c-95028557cd31 | d974d2a4-fc65-42ff-8138-cfcfd7381534 | 2021-07-27 | Warnings, Adverse reactions | d974d2a4-fc65-42ff-8138-cfcfd7381534 | ||
| 77d3d923-8571-4523-8e69-234ebeb7a5fd | 8ff9fc66-8367-445b-bb35-f6b112543d36 | 2021-06-16 | Boxed warning, Warnings, Adverse reactions | 77d3d923-8571-4523-8e69-234ebeb7a5fd 8ff9fc66-8367-445b-bb35-f6b112543d36 | ||
| Olanzapine | OLANZAPINE | Proficient Rx LP | e40d54bf-7334-4418-8a87-ff85941adec1 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Proficient Rx LP | 61424fa3-b09a-4267-a208-a7c7c3f69fe5 | 2020-10-01 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Aphena Pharma Solutions - Tennessee, LLC | b6ec5610-b4a6-4646-954a-0fe8b1d3e143 | 2020-05-05 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Proficient Rx LP | 7772a4c2-1fb1-412b-9e3b-ef3d693517a2 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.